Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease?: Results from the AmbOx trial

Andrew W Creamer; Shaney L Barratt

doi:10.1183/20734735.0002-2019

Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial

Andrew W Creamer^*, Shaney L Barratt

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

3 Citations (Scopus)

50 Downloads (Pure)

Abstract

The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http://ow.ly/uHC030nEzsz.

Original language	English
Pages (from-to)	140-143
Number of pages	4
Journal	Breathe (Sheffield, England)
Volume	15
Issue number	2
DOIs	https://doi.org/10.1183/20734735.0002-2019
Publication status	Published - 1 Jun 2019

Bibliographical note

Provisional acceptance date added, based on publication information,

Research Groups and Themes

Academic Respiratory Unit

Access to Document

10.1183/20734735.0002-2019

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via European Respiratory Society at 10.1183/20734735.0002-2019. Please refer to any applicable terms of use of the publisher.
Final published version, 85.4 KBLicence: CC BY-NC

Handle.net

Persistent link

Embargoed Document

Full-text PDF (author accepted manuscript)
Accepted author manuscript, 41.7 KB
Request copy

Cite this

@article{80efb401490045de9e3f87c20a07f5d2,

title = "Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease?: Results from the AmbOx trial",

abstract = "The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http://ow.ly/uHC030nEzsz.",

author = "Creamer, {Andrew W} and Barratt, {Shaney L}",

note = "Provisional acceptance date added, based on publication information, ",

year = "2019",

month = jun,

day = "1",

doi = "10.1183/20734735.0002-2019",

language = "English",

volume = "15",

pages = "140--143",

journal = "Breathe (Sheffield, England)",

issn = "1810-6838",

publisher = "European Respiratory Society",

number = "2",

}

TY - JOUR

T1 - Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease?

T2 - Results from the AmbOx trial

AU - Creamer, Andrew W

AU - Barratt, Shaney L

N1 - Provisional acceptance date added, based on publication information,

PY - 2019/6/1

Y1 - 2019/6/1

N2 - The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http://ow.ly/uHC030nEzsz.

AB - The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http://ow.ly/uHC030nEzsz.

U2 - 10.1183/20734735.0002-2019

DO - 10.1183/20734735.0002-2019

M3 - Article (Academic Journal)

C2 - 31191728

SN - 1810-6838

VL - 15

SP - 140

EP - 143

JO - Breathe (Sheffield, England)

JF - Breathe (Sheffield, England)

IS - 2

ER -